131 related articles for article (PubMed ID: 23902339)
1. Constitutive expression and activation of stress response genes in cancer stem-like cells/tumour initiating cells: potent targets for cancer stem cell therapy.
Torigoe T; Hirohashi Y; Yasuda K; Sato N
Int J Hyperthermia; 2013 Aug; 29(5):436-41. PubMed ID: 23902339
[TBL] [Abstract][Full Text] [Related]
2. Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells.
Hirohashi Y; Torigoe T; Inoda S; Takahashi A; Morita R; Nishizawa S; Tamura Y; Suzuki H; Toyota M; Sato N
Immunotherapy; 2010 Mar; 2(2):201-11. PubMed ID: 20635928
[TBL] [Abstract][Full Text] [Related]
3. Immunology of cancer stem cells in solid tumours. A review.
Maccalli C; Volontè A; Cimminiello C; Parmiani G
Eur J Cancer; 2014 Feb; 50(3):649-55. PubMed ID: 24333096
[TBL] [Abstract][Full Text] [Related]
4. Role of the tissue factor pathway in the biology of tumor initiating cells.
Garnier D; Milsom C; Magnus N; Meehan B; Weitz J; Yu J; Rak J
Thromb Res; 2010 Apr; 125 Suppl 2():S44-50. PubMed ID: 20434004
[TBL] [Abstract][Full Text] [Related]
5. Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role?
Rak J; Milsom C; Yu J
APMIS; 2008; 116(7-8):660-76. PubMed ID: 18834410
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives.
Leal JA; Lleonart ME
Cancer Lett; 2013 Sep; 338(1):174-83. PubMed ID: 22554710
[TBL] [Abstract][Full Text] [Related]
8. Can lung cancer stem cells be targeted for therapies?
Wu X; Chen H; Wang X
Cancer Treat Rev; 2012 Oct; 38(6):580-8. PubMed ID: 22436486
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells: in the line of fire.
Alison MR; Lin WR; Lim SM; Nicholson LJ
Cancer Treat Rev; 2012 Oct; 38(6):589-98. PubMed ID: 22469558
[TBL] [Abstract][Full Text] [Related]
10. [The concept and significance of cancer stem cells].
Haraguchi N; ishii H; Sakai D; Satoh T; Doki Y; Mori M
Nihon Geka Gakkai Zasshi; 2012 Mar; 113(2):204-9. PubMed ID: 22582581
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of HSF1 at serine 326 residue is related to the maintenance of gynecologic cancer stem cells through expression of HSP27.
Yasuda K; Hirohashi Y; Mariya T; Murai A; Tabuchi Y; Kuroda T; Kusumoto H; Takaya A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Tamura Y; Hirano H; Hasegawa T; Saito T; Sato N; Torigoe T
Oncotarget; 2017 May; 8(19):31540-31553. PubMed ID: 28415561
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Wnt1 expression reduces the enrichment of cancer stem cells in a mouse model of breast cancer.
Choi AR; Park JR; Kim RJ; Kim SR; Cho SD; Jung JY; Nam JS
Biochem Biophys Res Commun; 2012 Aug; 425(2):436-42. PubMed ID: 22846569
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor and cancer stem cells: is there a linkage?
Milsom C; Magnus N; Meehan B; Al-Nedawi K; Garnier D; Rak J
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2005-14. PubMed ID: 19628788
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cell markers in common cancers - therapeutic implications.
Klonisch T; Wiechec E; Hombach-Klonisch S; Ande SR; Wesselborg S; Schulze-Osthoff K; Los M
Trends Mol Med; 2008 Oct; 14(10):450-60. PubMed ID: 18775674
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms promoting physiological cells progression into tumorigenesis.
Korbut E; Ptak-Belowska A; Brzozowski T
J Physiol Pharmacol; 2012 Dec; 63(6):565-70. PubMed ID: 23388471
[TBL] [Abstract][Full Text] [Related]
16. Small proline-rich protein-1B is overexpressed in human oral squamous cell cancer stem-like cells and is related to their growth through activation of MAP kinase signal.
Michifuri Y; Hirohashi Y; Torigoe T; Miyazaki A; Fujino J; Tamura Y; Tsukahara T; Kanaseki T; Kobayashi J; Sasaki T; Takahashi A; Nakamori K; Yamaguchi A; Hiratsuka H; Sato N
Biochem Biophys Res Commun; 2013 Sep; 439(1):96-102. PubMed ID: 23954638
[TBL] [Abstract][Full Text] [Related]
17. The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice?
Sánchez-García I; Vicente-Dueñas C; Cobaleda C
Bioessays; 2007 Dec; 29(12):1269-80. PubMed ID: 18022789
[TBL] [Abstract][Full Text] [Related]
18. The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy.
Fábián Á; Vereb G; Szöllősi J
Cytometry A; 2013 Jan; 83(1):62-71. PubMed ID: 22997049
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer stem cells: an update.
Iqbal J; Chong PY; Tan PH
J Clin Pathol; 2013 Jun; 66(6):485-90. PubMed ID: 23322821
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells - A therapeutic target?
Maitland NJ; Collins AT
Curr Opin Mol Ther; 2010 Dec; 12(6):662-73. PubMed ID: 21154158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
